While GenePy may be useful as part of polygenic risk score to account for the heterogenous rare variation in genes associated with IBD or autoimmune disease such as ERAP1 and ERAP2, our data indicate the need for experimental data necessary to more clearly define how changes in these antigen-presenting proteins impact downstream cytokine signalling. The gene discussed is ERAP2; the disease is autoimmune disease.